How many patients discontinued lurbinectedin treatment?

How many patients discontinued lurbinectedin treatment in the studies?

The provided information does not include any trial results or discontinuation counts for lurbinectedin, so the number of patients who discontinued treatment cannot be determined from what’s currently available.

Where to find “discontinued” patient counts for lurbinectedin

To answer this precisely, you need the specific study (e.g., trial name/phase and indication) and the table or section reporting treatment discontinuation (often under “Discontinuations,” “Adverse events leading to discontinuation,” or “Overall discontinuation”). If you share the study link or the text/table you’re using, I can extract the exact discontinuation number.

Which “discontinuation” number do you mean?

Clinical reports can report different discontinuation metrics, such as:
- Patients who stopped treatment due to any reason
- Patients who discontinued due to adverse events
- Patients who discontinued due to disease progression
- Patients who discontinued in a particular arm/dose level

If you tell me which metric you mean and which study/arm, I’ll calculate or quote the exact number.